期刊文献+

p16、survivin、cyclin D1在膀胱尿路上皮癌中的表达及意义 被引量:6

The Expression of p16,CyclinD1 and Survivin in Transitional Cell Carcinoma of Bladder(TCC) and their Implications
原文传递
导出
摘要 目的:探讨抑癌基因p16、细胞周期蛋白cyclin D1和凋亡抑制基因survivin在膀胱移行细胞癌中的表达及意义。方法:膀胱移行细胞癌组67例,10例正常正常膀胱粘膜作为对照,采用免疫组织化学方法检测p16和cyclin D1、survivin蛋白表达,然后分析上述三种蛋白在膀胱癌组织中的表达情况,以及随着不同临床分期和病理分级表达的变化。结果:所有膀胱癌患者平均年龄58.16岁,其中男性患者38例。免疫组织化学分析表明,p16和cyclin D1、survivin蛋白均表达在细胞的细胞核。膀胱癌组织中P16表达明显低于正常对照组,而cyclin D1和survivin表达明显高于正常对照组。随着临床分期的进展,p16表达明显下降,cyclinD1表达明显上升;而随着膀胱癌病理分级升高,p16表达明显下降,survivin表达上升。此外,膀胱癌组织中,p16与cyclin D1p16之间存在着明确的负相关。结论:p16、cyclin D1、survivin在膀胱移行细胞癌的生物学行为中起重要作用,p16,cyclin D1和survivin与膀胱移行细胞癌的恶性进展有关。 Objective: To investigate the expression of p16,cyclin D1 or survivin as well as the clinical significance in transitional cell carcinoma of bladder.Methods: 67 specimens were derived by surgical operation.p16 protein,cyclin D1 and survivin were investigated by immunohistochemical method.Results: 67 patients with transitional cell carcinoma of bladder were enrolled in the study,with mean age of 58.16 years.38 cases were men.The expression of p16 was significant lower than the normal controls,and the expression of cyclin D1 and survivin were much higher than the normal controls.With the clinical stage progressed,the p16 expression level down-regulated,and cyclin D1 up-regulated;while with the tumor grade increased,the p16 expression down-regulated,and the survivin expression up-regulated.Moreover,the expression of p16 was negatively correlated to the expression of cyclin D1.Conclusions: p16,cyclin D1 and survivin play an important role in the behavior of biochemical in TCC.The expression of p16,cyclin D1 and survivin all involved in the progress of transitional cell carcinoma of bladder.
出处 《现代生物医学进展》 CAS 2012年第7期1309-1311,1305,共4页 Progress in Modern Biomedicine
关键词 P16 CYCLIN D1 SURVIVIN P16 Cyclin D1 Survivin
  • 相关文献

参考文献3

二级参考文献3

共引文献43

同被引文献37

  • 1于秀文,荣玮,孙玉荣,徐广有.MUC2、CDX2在大肠肿瘤中的表达及临床意义[J].中国现代医学杂志,2008,18(21):3115-3119. 被引量:8
  • 2王震凯,朱人敏.Wnt信号转导通路在肿瘤中的研究进展[J].医学研究生学报,2007,20(12):1294-1297. 被引量:29
  • 3ROJO M,LEGROS F,CHATEAU D,et al.Membrane topology andmito-chondrial targeting ofmitofusins,ubiquitous mammalian homologs of the transmembrane GTPase Fzo[J].Cell Sci,2002,115(8):1663-1674.
  • 4EURA Y,ISHIHARA N,YOKOTA S,et al.Twomitofusin proteins,mam-malian homologues of FZO,with distinct functions are both required formitochondrial fusion[J].J Biochem,2003,134(3):333-344.
  • 5ZHANG G,JIN H,LIN X,et al.Anti-tumor effects of Mfn2 in gastric cancer[J].IntJ Mol Sci,2013,14(7):13005-13021.
  • 6CHENG X,ZHOU D,WEI J.Cell-cycle arrest at G2/M and proliferation inhibition by adenovirus-expressed mitofusin-2 gene in human colorectal cancer cell lines[J].Neoplasma,2013,60(6):620-626.
  • 7JIN B,FU G,PAN H,et al.Anti-tumour efficacy of mitofusin-2 in urinary bladder carcinoma[J].Med Oncol,2011,28(8):5373-5380.
  • 8KAMB A,GRUIS N A,WEAVER FELDBAUS J.A cell cycle regulator potentially involved in genesis of many tumor types[J].Science,1994,264(5157):436-440.
  • 9胡泽成,赵华.结直肠肿瘤标志物CDX2的研究现状[J].中国普通外科杂志,2008,17(4):391-393. 被引量:9
  • 10李静(综述),尹林林(综述),王哲海(审校).p27、cyclin D1与恶性肿瘤[J].国际肿瘤学杂志,2008,35(5):336-339. 被引量:1

引证文献6

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部